ESR1 rs11568824: Understanding This Reproductive Genetic Variant
The rs11568824 variant is a genetic change located within the ESR1 gene, which provides instructions for making the estrogen receptor alpha protein. This variant has been studied for its potential associations with reproductive hormone signaling and the timing of natural menopause.
What each genotype means
Typical estrogen receptor signaling
This genotype represents the homozygous state for the major allele. Research into ESR1 variants often examines how these genetic differences influence reproductive hormone signaling and the timing of natural menopause, though the specific impact of this variant remains limited in clinical literature. You should view this as a common genetic background that does not imply a specific health condition.
This is the most common genotype globally, carried by the majority of individuals across most ancestral populations.
Common variant carrier
You carry one copy of the minor allele for this ESR1 variant. While ESR1 is a key gene for estrogen receptor function and reproductive health, the evidence linking this specific variant to clinical outcomes is limited and requires further study. This genotype is a normal variation found in many healthy individuals.
Carried by a significant portion of the population, consistent with the global minor allele frequency of approximately 0.28.
Minor allele homozygous
You carry two copies of the minor allele for this ESR1 variant. Current scientific evidence regarding this variant's role in reproductive hormone signaling or age at menopause is limited, and it is not considered a diagnostic marker for any specific health condition. Genetic associations with complex traits like menopause timing are often influenced by many genes and environmental factors, not just this single variant.
This genotype is less common than the others, appearing in a smaller subset of the population consistent with the reported minor allele frequency.
What is the rs11568824 Variant?
The rs11568824 variant is a single nucleotide polymorphism (SNP) located within the ESR1 gene on chromosome 6. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is found within the genomic region that encodes the estrogen receptor 1 protein. Because it sits within a gene responsible for critical hormonal pathways, researchers investigate whether this change influences how the body processes or responds to estrogen. It is important to note that while this variant is cataloged in public databases, its functional impact on the protein's structure or activity remains a subject of ongoing scientific inquiry rather than a confirmed clinical marker.
The Role of the ESR1 Gene
The ESR1 gene encodes the estrogen receptor alpha, a ligand-activated transcription factor. This protein plays a fundamental role in the human body by binding to estrogen and regulating the expression of various genes involved in growth, metabolism, sexual development, and reproductive function. Because estrogen signaling is essential for maintaining bone density, cardiovascular health, and reproductive cycles, the ESR1 gene is highly active in many tissues, including the ovaries, uterus, and breast tissue. Variations in this gene can theoretically alter the sensitivity of cells to estrogen, which is why scientists study these markers to better understand the biological diversity in reproductive health and the timing of life-stage transitions like menopause.
Research and Evidence Strength
Current research into rs11568824 is categorized as having limited evidence regarding its clinical impact. While some studies have explored associations between ESR1 polymorphisms and reproductive traits—such as the age of natural menopause or hormone levels—these findings are often specific to certain populations or require larger, more diverse cohorts to confirm. It is common in genomics for initial associations to appear in smaller studies, but these results do not always translate into broad clinical applications. Consequently, this variant is not currently used as a diagnostic tool or a predictor of health outcomes in standard medical practice. The scientific community continues to evaluate how such variants interact with environmental and lifestyle factors to influence complex human traits.
Population Frequency
According to data from the Genome Aggregation Database (gnomAD), the rs11568824 variant has a global allele frequency of approximately 0.28. This indicates that the variant is relatively common across diverse human populations. Genetic frequency can vary significantly depending on ancestral background, and gnomAD provides stratified data to help researchers understand these differences. Because this variant is found at a high frequency in the general population, it is considered a common genetic polymorphism rather than a rare mutation. Understanding these frequencies is a standard part of genomic research, as it helps scientists distinguish between common variations that contribute to normal human diversity and rare variants that may be linked to specific health conditions.
Interpreting Your Genetic Information
If you have received information about your rs11568824 genotype, it is important to view it within the context of current scientific limitations. This variant is not a diagnostic test for any disease, nor does it provide a definitive prediction of your reproductive health or the timing of menopause. Genetic associations are statistical in nature and often represent only a tiny fraction of the factors that influence human biology. You cannot use this information to make medical decisions or change your health regimen. If you have questions about your reproductive health, hormone levels, or family history, the most appropriate step is to consult with a qualified healthcare provider or a genetic counselor who can interpret your health history in a comprehensive and personalized manner.
How common is this variant?
The rs11568824 variant is common, with a global allele frequency of approximately 0.28 across populations represented in the gnomAD database.
Frequently asked questions
Is rs11568824 a cause of early menopause?
No, rs11568824 is not considered a cause of early menopause. While some research has explored links between ESR1 variants and the timing of menopause, the evidence is limited and does not establish a direct causal relationship.
Should I be worried if I have the G allele?
No, there is no reason for concern. The G allele is a common genetic variation found in a large portion of the population and is not associated with any known disease or health risk.
Can I use this SNP to predict my fertility?
No, this SNP cannot be used to predict fertility. Reproductive health is a complex trait influenced by many genes, environmental factors, and lifestyle choices, and this single variant does not provide meaningful predictive information.
Where can I find more information about ESR1?
You can find reliable information about the ESR1 gene through resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide comprehensive, peer-reviewed summaries of gene functions and their roles in human health.
Sources & further reading
Educational information only, last refreshed 9/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11568824?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ESR1
This variant in the estrogen receptor 1 gene is associated with an increased risk of endometriosis and may influence cognitive aging.
Estrogen receptor 1 variant associated with altered circulating estradiol levels, follicular maturation, and variability in age at natural menopause.
Variant in estrogen receptor 1 associated with variation in female reproductive timing, including age at menarche and natural menopause onset.
Common polymorphism in estrogen receptor alpha (ESR1) affecting target tissue responsiveness to estrogen, recurrent pregnancy loss risk, and bone-reproductive axis interactions.
Estrogen receptor 1 regulatory variant associated with variation in timing of menarche and bone density response to sex hormones.
Estrogen receptor 1 missense and intronic regulatory variation associated with ovarian responsiveness and fertilization rates in assisted reproductive technology.